email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
706 - 720
of 3612 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Jemincare Out-Licenses Prostate Cancer Candidate to Genentech for $650 Million
$5.00
Available
Wyze Biotech Closes A Rounds with $30 Million for Universal Immune Cell Products
$5.00
Available
Everest Returns Greater China Rights for Trodelvy to Gilead for $455 Million
$5.00
Available
SinocellTech Says Anti-CD20 mAb Shows Non-Inferiority to Genetech’s Rituxan
$5.00
Available
Bennu Bio Closes $15 Million Funding for T-Cell Therapies
$5.00
Available
Frontier Reports Positive Results from Early Trial of COVID-19 Therapy
$5.00
Available
Insilico Closes $35 Million D2 Round; Will Expand AI Beyond Drug Discovery
$5.00
Available
Axcynsis Opens Shanghai R&D Center; Raises $15 Million
$5.00
Available
LianBio Completes Enrollment of Phase III Trial for Cardiomyopathy Therapy
$5.00
Available
Arbele Starts Australian Trial of CDH17xCD3 Bispecific for GI Cancers
$5.00
Available
Hansoh Enters $170 Million Agreement for Endometriosis/Uterine Fibroid Therapy
$5.00
Available
Inmagene and HutchMed Start Global Trial of BTK Inhibitor
$5.00
Available
Epigenic Therapeutics Raises $20 Million in Angel and Pre-A Rounds for Epigenetic Drugs
$5.00
Available
ImmVira Granted US Orphan Drug Status for Oncolytic Virus Candidate in Glioma
$5.00
Available
Innovent to Partner two Sanofi Cancer Assets in China; Sanofi Invests $305 Million in Innovent
$5.00
Available